Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Kidney Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00276614
What this trial is testing

Bortezomib in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Jonsson Comprehensive Cancer Center 4
Early research (Phase 1)Looking for participantsNCT06819293
What this trial is testing

IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Clear Renal Cell CarcinomaAdult
Grit Biotechnology 12
Testing effectiveness (Phase 2)Study completedNCT00035243
What this trial is testing

EPO906 Therapy in Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Neoplasms
Novartis Pharmaceuticals 53
Testing effectiveness (Phase 2)Study completedNCT03494816
What this trial is testing

Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaNon-metastatic Renal Cell Carcinoma
Scottish Clinical Trials Research Unit 24
Testing effectiveness (Phase 2)Looking for participantsNCT07227415
What this trial is testing

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Who this might be right for
Carcinoma, Renal CellAdvanced Renal Cell CarcinomaRenal Cancer+10 more
Pfizer 224
Early research (Phase 1)Looking for participantsNCT07564232
What this trial is testing

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT00226798
What this trial is testing

Immunochemotherapy for Metastatic Renal Cell Carcinoma

Who this might be right for
Adenocarcinoma Clear Cell
Rambam Health Care Campus 45
Not applicableLooking for participantsNCT06676527
What this trial is testing

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

Who this might be right for
NeoplasmsKidney NeoplasmsUrologic Neoplasms+10 more
Jinling Hospital, China 39
Testing effectiveness (Phase 2)Study completedNCT01727089
What this trial is testing

Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Testing effectiveness (Phase 2)Looking for participantsNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)Study completedNCT00465179
What this trial is testing

Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer

Who this might be right for
Renal Cell CancerKidney Cancer
M.D. Anderson Cancer Center 61
Testing effectiveness (Phase 2)Ended earlyNCT01185366
What this trial is testing

Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 73
Not applicableNo Longer AvailableNCT05941637
What this trial is testing

An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)

Who this might be right for
Clear Cell Kidney CancerKidney CancerKidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
Lynkcell Europe
Not applicableStudy completedNCT00898365
What this trial is testing

Study of Kidney Tumors in Younger Patients

Who this might be right for
Adult Cystic NephromaAnaplastic Kidney Wilms TumorAngiolipoma+22 more
Children's Oncology Group 8,000
Early research (Phase 1)Looking for participantsNCT05856981
What this trial is testing

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultMetastatic Solid TumorRefractory Cancer+4 more
Sairopa B.V. 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07077083
What this trial is testing

CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)ccRCC
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT04535687
What this trial is testing

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1
Early research (Phase 1)Study completedNCT01497821
What this trial is testing

AMG 172 First in Human Study in Patients With Kidney Cancer

Who this might be right for
Renal Cell AdenocarcinomaClear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma+1 more
Amgen 37
Early research (Phase 1)Study completedNCT01331135
What this trial is testing

Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors

Who this might be right for
Ewing's SarcomaOsteosarcomaAstrocytoma+13 more
Emory University 18
Next Page